Compare IPCA Labs with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ALKEM LABORATORIES IPCA LABS/
ALKEM LABORATORIES
 
P/E (TTM) x 25.4 21.5 118.3% View Chart
P/BV x 4.9 4.9 100.6% View Chart
Dividend Yield % 0.4 1.0 44.1%  

Financials

 IPCA LABS   ALKEM LABORATORIES
EQUITY SHARE DATA
    IPCA LABS
Mar-21
ALKEM LABORATORIES
Mar-21
IPCA LABS/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,4563,150 78.0%   
Low Rs1,3712,224 61.7%   
Sales per share (Unadj.) Rs423.3741.4 57.1%  
Earnings per share (Unadj.) Rs90.6135.3 66.9%  
Cash flow per share (Unadj.) Rs107.1158.3 67.6%  
Dividends per share (Unadj.) Rs4.0030.00 13.3%  
Avg Dividend yield %0.21.1 18.7%  
Book value per share (Unadj.) Rs370.6616.8 60.1%  
Shares outstanding (eoy) m126.85119.57 106.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.53.6 124.7%   
Avg P/E ratio x21.119.9 106.4%  
P/CF ratio (eoy) x17.917.0 105.3%  
Price / Book Value ratio x5.24.4 118.5%  
Dividend payout %4.422.2 19.9%   
Avg Mkt Cap Rs m242,728321,244 75.6%   
No. of employees `000NANA-   
Total wages/salary Rs m10,13616,210 62.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,69988,650 60.6%  
Other income Rs m1,2922,332 55.4%   
Total revenues Rs m54,99190,982 60.4%   
Gross profit Rs m14,81219,424 76.3%  
Depreciation Rs m2,0922,746 76.2%   
Interest Rs m123589 20.8%   
Profit before tax Rs m13,89018,421 75.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4012,243 107.0%   
Profit after tax Rs m11,48816,178 71.0%  
Gross profit margin %27.621.9 125.9%  
Effective tax rate %17.312.2 142.0%   
Net profit margin %21.418.2 117.2%  
BALANCE SHEET DATA
Current assets Rs m34,37069,288 49.6%   
Current liabilities Rs m11,33136,041 31.4%   
Net working cap to sales %42.937.5 114.4%  
Current ratio x3.01.9 157.8%  
Inventory Days Days4920 248.8%  
Debtors Days Days666 8.3%  
Net fixed assets Rs m26,29534,825 75.5%   
Share capital Rs m254239 106.1%   
"Free" reserves Rs m46,76373,517 63.6%   
Net worth Rs m47,01773,756 63.7%   
Long term debt Rs m365343 106.7%   
Total assets Rs m60,664104,114 58.3%  
Interest coverage x114.232.3 354.0%   
Debt to equity ratio x00 167.4%  
Sales to assets ratio x0.90.9 104.0%   
Return on assets %19.116.1 118.8%  
Return on equity %24.421.9 111.4%  
Return on capital %29.625.7 115.3%  
Exports to sales %022.1 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA19,555 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27,17219,555 139.0%   
Fx outflow Rs m7,9492,467 322.1%   
Net fx Rs m19,22317,088 112.5%   
CASH FLOW
From Operations Rs m10,90112,649 86.2%  
From Investments Rs m-5,207-9,985 52.1%  
From Financial Activity Rs m-3,058-2,718 112.5%  
Net Cashflow Rs m2,636-17 -15,326.7%  

Share Holding

Indian Promoters % 46.3 57.1 81.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.0 19.6 224.9%  
FIIs % 11.0 5.4 203.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 42.9 125.3%  
Shareholders   115,335 81,869 140.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 111 Points Lower, Nifty Holds 15,750; ONGC, Reliance Crash, while ITC & Bajaj Twins Gain 4%(Closing)

After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

Wait! Don't Buy the Smallcap 'Dip' Just Yet(Profit Hunter)

Jun 20, 2022

Why this may not be the best time to buy smallcaps.

5 Consistent Compounding Stocks Available at Discount. Time to Buy?(Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Looking for Value Stocks Amid Volatile Times? Consider These 5 Stocks(Views On News)

Jun 20, 2022

These value stocks have the potential to deliver good returns in the long run. Watch out for them.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jul 1, 2022 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - BAJAJ HEALTHCARE COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS